Book Reviews | Gordon Campbell | News Flashes | Scoop Features | Scoop Video | Strange & Bizarre | Search

 


Hormone Therapy Makes Comeback--Are Cigarettes Next?

Hormone Therapy Makes Comeback--Are Cigarettes Next?

by Martha Rosenberg
November 9, 2012


Click for big version.

It has been almost ten years since a US government study found that hormone replacement therapy (HRT) did not prevent heart disease and memory loss as advertised but increased the risk of heart attacks by 29 percent and doubled the risk of dementia. Oops.

That was not all the bad news that emerged about HRT. It also increased the risk of breast cancer by 26 percent, stroke by 41 percent, doubled the risk of blood clots and increased the risk of hearing loss, gall bladder disease, urinary incontinence, asthma, the need for joint replacement, melanoma, ovarian, endometrial and lung cancers and non-Hodgkin's lymphoma, according to medical journals.

It was not exactly the fountain of youth it was billed as by hormone drug maker Wyeth (now Pfizer) in high-budget menopause awareness TV ads starring model Lauren Hutton.

In fact, HRT was such a scourge against women, in the first year that millions quit, 2003, the incidence of US breast cancer fell seven percent. It fell 15 percent among women whose tumors were fed by estrogen. Fourteen thousand women who were expected to get breast cancer didn't said news reports. And it wasn't just breast cancer women were spared: heart attack and ovarian cancer rates also fell when women quit HRT, said news reports.

The statistics must have been embarrassing to cancer researchers and public health officials. Not only was a major cause of breast cancer hidden in plain sight, the war on cancer should apparently have been a war on cancer-causing drugs!

It was even more embarrassing because the whole sequence happened before! In 1975, a Food and Drug Administration (FDA) panel found a link between Premarin (a Wyeth HRT drug) and endometrial cancer and when women quit the drug by the millions--the same thing happened. "There was a sharp downward trend in the incidence of endometrial cancer that paralleled a substantial reduction in prescriptions for replacement estrogens," reported the New England Journal of Medicine (NEJM) in 1979.

Not wanting to lose its billion dollar HRT franchise, Wyeth's medical director wrote doctors at the time that HRT still had "proven benefits" at the "the lowest maintenance dose" and that it was "simplistic indeed to attribute an apparent increase in the diagnosis of endometrial carcinoma solely to estrogen therapy."

Thirty years later, when cancer rates again dropped, Wyeth also bit back. It announced the reason women weren't seeing prevention of heart disease and memory loss from HRT was they weren't taking it soon enough. They needed to start treatment sooner. Ka-ching. The early treatment campaign was called the "timing theory."

Soon a National Institute on Aging trial and privately funded trials on "menopausal" primates, both led by Wyeth-funded investigators, were underway at major medical centers. After all, before 2002, millions of American women, perhaps the majority, had been on HRT. Wasn't there a way to get them back?

Last month the hormone revival campaign hit pay dirt. Women "who took treatments such as Pfizer Inc.'s estrogen pill Premarin within five years of menopause lowered their chance of Alzheimers by 30 percent," wrote the Washington Post about a study in the journal Neurology.

"It's really important to distinguish between studies that are able to look at early use of hormone therapy versus later use," said Pauline M. Maki, PhD on WebMD about the same study. Maki has received research support from Wyeth according to a July 2010 article in the journal Menopause. WebMD just imported a new CEO from Pfizer.

The study was funded by the National Institute on Aging (NIA) not Big Pharma. But NIA is so collegial with hormone makers, it funded the North American Menopause Society's entire 2009 annual meeting replete with Wyeth-funded doctor presenters and even Wyeth employee presenters. It also invited top Wyeth officials for a "Where Are We Now?" meeting soon after its products were linked to cancer/heart disease/blood clots/stroke/dementia.

Even if HRT did lower Alzheimer risk--would it be ethical to prescribe it in light of its other risks or even conduct trials? HRT's negative cognitive effects are so well known, a 2006 Reuters story began, "Regular exercise may prevent the mental decline associated with the long-term use of hormone replacement therapy (HRT)." And two studies in the January 13, 2009 issue of Neurology link HRT to brain shrinkage.

Hormone markers have also floated the idea that early HRT would prevent heart disease and/or cancer. But a 2011 analysis from the Million Women Study, sponsored by England's National Health Service, found women who took hormones the earliest, before or soon after the onset of menopause, were at the greatest risk of getting breast cancer.

Why does the government let--and even help--Big Pharma market HRT like it's a brand new product instead of the cause of two cancer epidemics--so far? Would anyone tell cigarette smokers to start smoking earlier?

*************

The complete story of unethical marketing of HRT to women is found in Martha Rosenberg's recent book, Born with a Junk Food Deficiency.

© Scoop Media

 
 
 
 
 
Top Scoops Headlines

 

Ramzy Baroud: Gaza’s Resistance Will Not Be Crushed

On the 13th day of Israel’s so-called Operation Protective Edge, stories of entire families collectively pulverized, women and children keenly targeted by Israeli soldiers saturate the media. Until now, 430 Palestinians have been killed, mostly women and ... More>>

ALSO:

Ian Anderson: Rearranging The Deck Chairs On The Titanic? The Labour Party And MANA

Early in July this year, Labour Party leader David Cunliffe made headlines by apologising for being a man. Stoked by capitalist media sensation, Prime Minister John Key responded that “not all men” abuse women. More>>

Shobha Shukla: Break The Silos: Drug Use, HIV, HCV, TB, Laws And Funding

Viet Nam is one of the countries in the world that has made remarkable progress over the last decade in not only making harm reduction and HIV services available and accessible for people who use drugs but also reforming laws for supportive health ... More>>

ALSO:

Fiona Gordon: Illegal Wildlife Trading: The Global Response

At the closing session of the inaugural United Nations Environment Assembly (UNEA) in Nairobi last month, United Nations Secretary General Ban Ki-moon said, “We need to act decisively to change humanity’s relationship with our planet.” More>>

Faisal Al-Asaad: Gaza: McCully’s Calls For Restraint On Both Sides Is Side-Taking Itself

Since June 12th, the world’s attention has been squarely focused on the events unfolding in the West Bank, Gaza and the occupied territories. The disappearance of three Israeli youths who were later found dead prompted a flurry of condemnations ... More>>

ALSO:

Tania Billingsley: Demand For Accountability On Sexual Assault

Since my assault I feel that people have been assuming that my idea of justice is to have Rizalman found guilty in a New Zealand court. While it is an important part of justice being done, my main reason for wanting this is not for my own sense of ... More>>

Leslie Bravery: Hold The Perpetrator To Account, Not The Victim!

In a 4 July 2014 statement to Scoop Independent News, on the violent deaths of four young people in the Israeli Occupied West Bank and East Jerusalem, New Zealand's Foreign Minister Murray McCully made the following comments: 'The recent killing ... More>>

ALSO:

Santon Tekege: Investigative Report Into Oil Palm In Nabire Regency, Papua

Several companies’ plans to invest in the oil palm sector in Nabire have met with local opposition. People from the Yerisiam and Wate ethnic groups have staged several peaceful actions in Nabire against one of these companies, PT Nabire Baru1. More>>

ALSO:

Get More From Scoop

 
 
TEDxAuckland
 
 
 
 
Top Scoops
Search Scoop  
 
 
Powered by Vodafone
NZ independent news